Mutation of lipoprotein processing pathway gene lspA or inhibition of LspA activity by globomycin increases MRSA resistance to β-lactam antibiotics
Antimicrobial Agents and Chemotherapy · 2026
DOI: 10.1128/aac.01276-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Claire Fingleton und 4 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology, School of Natural Sciences, National University of Ireland, Galway, Ireland. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, beta-Lactams, Bacterial Proteins. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Board, Swedish Research Council for Sustainable Development (FORMAS), Research Ireland.
Abstract (Originalsprache)
Resistance to β-lactam antibiotics in methicillin-resistant Staphylococcus aureus is mediated by the mecA -encoded, β-lactam-resistant transpeptidase, penicillin-binding protein 2a (PBP2a), which is capable of crosslinking peptidoglycan in the presence of β-lactam antibiotics. Here, we report that mutation of the lipoprotein signal peptidase II gene, lspA , from the lipoprotein processing pathway, significantly increased β-lactam resistance in MRSA, independent of changes in PBP2a levels or peptidoglycan composition. Exposure of MRSA to the LspA inhibitor globomycin also increased β-lactam resistance. Mutation of lgt , which encodes diacylglycerol transferase (Lgt) responsible for synthesis of the LspA substrate, did not impact β-lactam susceptibility. Furthermore, mutation of lgt in an lspA background restored β-lactam resistance to wild-type levels. These data suggest that accumulation of the LspA substrate, diacylglyceryl-lipoprotein, is associated with increased β-lactam resistance in MRSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology, School of Natural Sciences, National University of Ireland, Galway, Ireland.
- Department of Molecular Biology, Umeå University, MIMS - Laboratory for Molecular Infection Medicine Sweden, Umeå, Sweden.
ORCID-Profile: Merve S Zeden, Felipe Cava, James P O'Gara
Förderung
- Health Research Board
- Swedish Research Council for Sustainable Development (FORMAS)
- Research Ireland
Zitieren
APA
Fingleton, C., Zeden, M. S., Bueno, E., Cava, F., & O'Gara, J. P. (2026). Mutation of lipoprotein processing pathway gene lspA or inhibition of LspA activity by globomycin increases MRSA resistance to β-lactam antibiotics. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01276-25
Vancouver
Fingleton C, Zeden MS, Bueno E, Cava F, O'Gara JP. Mutation of lipoprotein processing pathway gene lspA or inhibition of LspA activity by globomycin increases MRSA resistance to β-lactam antibiotics. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01276-25
BibTeX
@article{Fingleton2026,
author = {Fingleton, Claire and Zeden, Merve S and Bueno, Emilio and Cava, Felipe and O'Gara, James P},
title = {Mutation of lipoprotein processing pathway gene lspA or inhibition of LspA activity by globomycin increases MRSA resistance to β-lactam antibiotics},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.01276-25}
}
EUVIMED